← Leaderboards
Robert S Gaston
University Of Alabama At Birmingham
$59,058
Attributed
$59,058
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$59,058 · 2
By mechanism
M01$59,058 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Hui Xu$7,316,820
- Santosh Kumar Katiyar$4,108,412
- Anupam Agarwal$17,840,868
- Huang-Ge Zhang$11,876,098
- Judith M. Thomas$6,258,648
Others in their field
Top investigators on “Transplant Rejection”
- Peter Scott Heeger · Case Western Reserve University$55,660,057
- Joren C Madsen · Massachusetts General Hospital$54,311,889
- Megan Sykes · Columbia University Health Sciences$43,888,406
- Mohamed H Sayegh · University Of Pennsylvania$37,864,018
- Ignacio E. Sanz · University Of Rochester$34,033,760
- Allan D. Kirk · Emory University$32,355,276
Research focus
Transplant RejectionClinical ResearchCyclosporinesHuman SubjectKidney TransplantationPharmacokineticsDrug Adverse EffectDrug Screening /EvaluationHomologous TransplantationPrednisoneHuman Therapy EvaluationImmunosuppressiveKidney Disorder ChemotherapyArtificial ImmunosuppressionMonoclonal AntibodyAzathioprineChemopreventionOral AdministrationCombination Chemotherapy
Grant awards (6)
ANTI TAC WITH 3 DRUG THERAPY FOR PREVENTION OF ACUTE ALLOGRAFT REJECTION$0
M01 · FY2002 · RR
ORAL SOLUTIONS OF SANG35 VERSUS NEORAL IN STABLE ADULT RENAL ALLOGRAFTS$0
M01 · FY2002 · RR
ANTI TAC WITH 3 DRUG THERAPY FOR PREVENTION OF ACUTE ALLOGRAFT REJECTION$0
M01 · FY2001 · RR
ORAL SOLUTIONS OF SANG35 VERSUS NEORAL IN STABLE ADULT RENAL ALLOGRAFTS$0
M01 · FY2001 · RR
ANTI TAC WITH 3 DRUG THERAPY FOR PREVENTION OF ACUTE ALLOGRAFT REJECTION$29,529
M01 · FY2000 · RR
ORAL SOLUTIONS OF SANG35 VERSUS NEORAL IN STABLE ADULT RENAL ALLOGRAFTS$29,529
M01 · FY2000 · RR